Transthyretin familial amyloid polyneuropathy: an update

Non-coding variants contribute to the clinical heterogeneity of TTR amyloidosis

(2017) Andrea Iorio et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

mtDNA copy number associated with age of onset in familial amyloid polyneuropathy

(2017) Diana Santos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy

(2017) Andrea Cortese et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds

(2017) Gonglu Liu et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal

(2017) Miguel Alves-Ferreira et al.   MOLECULAR NEUROBIOLOGY

Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial

(2017) Peter J. Dyck et al.   MUSCLE & NERVE

Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy

(2017) Teruaki Masuda et al.   NEUROLOGY

Sural nerve injury in familial amyloid polyneuropathy

(2017) Jennifer Kollmer et al.   NEUROLOGY

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

(2016) Márcia Waddington Cruz et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides

(2016) Elizabeth J. Ackermann et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin

(2016) Jeffrey N. Higaki et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

(2016) Adam J. Loavenbruck et al.   ANNALS OF NEUROLOGY

Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE

(2016) Julian D. Gillmore et al.   CIRCULATION

The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy

(2016) José Castro et al.   CLINICAL NEUROPHYSIOLOGY

Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy

(2016) Philippe Kerschen et al.   Current Treatment Options in Neurology

Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study

(2016) Violaine Planté-Bordeneuve et al.   JOURNAL OF NEUROLOGY

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

(2016) A. Cortese et al.   JOURNAL OF NEUROLOGY

“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy

(2016) Isabel Conceição et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Clinical measures in transthyretin familial amyloid polyneuropathy

(2016) Teresa Coelho et al.   MUSCLE & NERVE

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy

(2016) Hartmut H.-J. Schmidt et al.   MUSCLE & NERVE

Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy

(2016) Haruki Koike et al.   NEUROLOGY

Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis

(2016) Yoshiki Sekijima et al.   NEUROLOGY

Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures

(2016) Sunil M. Kurian et al.   Theranostics

Familial amyloid polyneuropathy in Portugal: New genes modulating age-at-onset

(2016) Diana Santos et al.   Annals of Clinical and Translational Neurology

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa

(2016) Daniel R. Jacobson et al.   Molecular Genetics & Genomic Medicine

Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis

(2015) Yoshiki Sekijima et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France

(2015) Louise-Laure Mariani et al.   ANNALS OF NEUROLOGY

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

(2015) Thibaud Damy et al.   EUROPEAN HEART JOURNAL

Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M)

(2015) Diana Santos et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK

(2015) A S Carr et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

(2015) Morie A. Gertz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Liver transplantation in transthyretin amyloidosis: Issues and challenges

(2015) Andreia Carvalho et al.   LIVER TRANSPLANTATION

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

(2015) Duncan B. Richards et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans

(2015) C. Cristina Quarta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver Transplantation for Hereditary Transthyretin Amyloidosis

(2015) Bo-Göran Ericzon et al.   TRANSPLANTATION

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

(2015) John L. Berk et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibodies and protein misfolding: From structural research tools to therapeutic strategies

(2014) Erwin De Genst et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography

(2014) Jennifer Kollmer et al.   BRAIN

Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy

(2014) Violaine Plante-Bordeneuve   JOURNAL OF NEUROLOGY

CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings

(2014) L. F. Maia et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

(2013) Teresa Coelho et al.   JOURNAL OF NEUROLOGY

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

(2013) Teresa Coelho et al.   NEW ENGLAND JOURNAL OF MEDICINE

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin

(2013) S. C. Penchala et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

(2012) C. E. Bulawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Familial amyloid polyneuropathy

(2011) Violaine Planté-Bordeneuve et al.   LANCET NEUROLOGY

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

(2010) Karl Bodin et al.   NATURE

Lipid-like materials for low-dose, in vivo gene silencing

(2010) K. T. Love et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA